Assembly Biosciences (ASMB) Income towards Parent Company (2010 - 2026)

Assembly Biosciences' Income towards Parent Company history runs 17 years deep, the most recent figure standing at -$9.1 million for Q1 2026.

• In Q1 2026, Income towards Parent Company fell 2.96% year-over-year to -$9.1 million; the TTM figure through Mar 2026 stood at -$6.4 million (up 84.01% YoY), while the FY2025 annual figure was -$6.1 million, up 84.76% from the prior year.
• Income towards Parent Company was -$9.1 million for Q1 2026 at Assembly Biosciences, down from $22.1 million in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of $22.1 million in Q4 2025 to a low of -$24.5 million in Q2 2022.
• Historically, Income towards Parent Company has averaged -$12.3 million across 5 years, with a median of -$11.0 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Income towards Parent Company fell 23.09% in 2022, then surged 313.74% in 2025.
• A 5-year view of Income towards Parent Company shows it stood at -$22.4 million in 2022, then jumped by 51.05% to -$11.0 million in 2023, then rose by 5.72% to -$10.3 million in 2024, then jumped by 313.74% to $22.1 million in 2025, then slumped by 141.1% to -$9.1 million in 2026.
• The last three Income towards Parent Company figures came in at -$9.1 million (Q1 2026), $22.1 million (Q4 2025), and -$9.2 million (Q3 2025), per Business Quant data.